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Abstract Group B Streptococcus (GBS) causes severe infec-
tions in infants and in immunocompromised adults. GBS path-
ogenicity varies between and within serotypes, with
considerable variation in genetic content between strains. For
this reason, it is important to be able to carry out immediate and
comprehensive diagnostics of these infections. Seven genes
important for screening of GBS infection were detected: cfb
gene encoding the CAMP factor presented in every GBS; the
cps operon genes such as cps1aH, cps1a/2/3IJ, and cps5O
specific for capsular polysaccharide types Ia, III, and V, respec-
tively; macrolide resistance genes ermB and mefA/E; and the
gbs2018 S10 region specific for ST17 hypervirulent clone.
Standardization of multiplex PCR with the use of seven primer
pairs was performed on 81 bacterial strains representing differ-
ent GBS isolates (n075) and other Gram-positive cocci
(n010). Multiplex PCR can be used as an effective screening
method to detect different sequences important for the screen-
ing of GBS infection.
Introduction
Streptococcus agalactiae (group B Streptococcus; GBS) is
one of the major etiological causes of sepsis and neonatal
meningitis in the USA and some European countries
(Centers for Disease Control and Prevention 2009; Law et
al. 2005). In recent years, GBS has been isolated more often
from the immunosuppressed patients (Verani et al. 2010).
Up to the present time, nine serotypes based on the GBS
capsular polysaccharides (CPS) have been identified (Ia, Ib,
and II–VIII), and as recently a new serotype (IX) has been
proposed (Johri et al. 2006; Slotved et al. 2007). In the USA
and Europe, serotypes Ia, II, III, and Vare found in 80–90%
of all clinical isolates (Brimil et al. 2006). On the other hand,
serotypes VI and VIII are the most common in Japan
(Lachenauer et al. 1999). Polysaccharide capsule has been
recognized as one of the most important antiphagocytic
virulence factors (Johri et al. 2006). As a result, GBS dis-
plays significant differences in virulence depending on the
CPS. Serotype Ia is responsible for most cases of early onset
disease in newborns, serotype III for late onset disease
(Persson et al. 2004). Serotype V, particularly macrolide-
resistant strains, is responsible for infections in the elderly or
immunodeficient patients (Persson et al. 2004).
In the recent years, the hypervirulent ST17 clone defined
with the application of multilocus sequence typing (MLST)
method associated with a very high mortality rate in
newborns with early onset disease has been of great interest
(Manning et al. 2009; Poyart et al. 2008).
Penicillin is the recommended drug because GBS resis-
tance has not been reported. However, for people allergic to
penicillin, the alternative drugs are macrolides or lincosa-
mides (Kotarski et al. 2008; Verani et al. 2010). Two main
antibiotic resistance mechanisms are described for S.
agalactiae. The first one is MLSB phenotype character-
ized by cross-resistance to macrolides, lincosamides, and
streptogramins B which are encoded by the erm genes
(erythromycin ribosomal methylase). The second mech-
anism is M phenotype which is associated with the
expression of the mefA/E genes (macrolide resistance)
(Gherardi et al. 2007).
As a result, the objective of our studies was to
design and standardize the multiplex PCR method as a
technique to identify seven different DNA factors of
GBS strains: (1) S. agalactiae species, (2) serotype Ia,
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(3) serotype III, (4) serotype V, (5) the macrolide resis-
tance gene ermB, (6) the macrolide resistance genes mef
A/E, and (7) hypervirulent ST17 clone associated with
the pathogenicity of GBS whose presence may influence
the prescribed therapeutic decisions.
Materials and methods
Examined GBS strains
The S. agalactiae strains used in the examinations were
derived from the collection of the Chair of Microbiology,
Jagiellonian University Medical College described in our
previous paper (Brzychczy-Włoch et al. 2012). The total of
75 isolates coming from the clinical materials representing
seven most important genetic factors significant for GBS
diagnostic and epidemiological purposes were selected for
this study. The reference GBS strains, such as: 11360
National Collection of Type Cultures (NCTC)—serotype
Ia; 2134 DSM (German Collection of Microorganisms
and Cell Cultures)—serotype II; 12403 American Type
Culture Collection (ATCC)—serotype III; and BAA-611
ATCC—serotype V were tested. The hypervirulent ST17
clone of GBS came from our collection and it was con-
firmed by MLST method. Moreover, non-GBS strains be-
longing to the beta-hemolytic Gram-positive cocci that can be
most frequently confused with GBS were studied:
Streptococccus pyogenes—strains 2071 DSM and 20565
DSM, Enterococcus faecalis—strains 20478 DSM and
19434 ATCC, Staphylococcus aureus—24167 DSM and
Staphylococcus haemolyticus—strain 29970 ATCC.
The PCR method to confirm S. agalactiae species
and detect the examined infection-related factors
For the purpose of DNA isolation the specific bacterial
isolates were cultured in the TSB medium (Difco) at the
temperature of 37°C for 24 h. The bacterial DNA was
isolated with the use of the nucleic acid isolation kit
(Genomic Mini, DNA Gdansk) pursuant to the manufac-
turer’s protocol. Afterwards, the separate PCR amplifica-
tions were conducted on the DNA isolates to detect the
presence of cfb gene encoding the CAMP factor presented
in every GBS (Ke et al. 2000); the cps operon genes
cps1aH, cps1a/2/3IJ and cps5O specific for CPS types Ia,
III and V, respectively (Poyart et al. 2007); macrolide resis-
tance genes ermB and mefA/E (Sutcliffe et al. 1996); the
gbs2018 S10 region specific for ST17 hypervirulent clone
(Lamy et al. 2006). The detection of ST17 clone was
additionally confirmed with the application of the
MLST method list of housekeeping genes (Jones et al.
2003) and primers (Manning et al. 2008).
The multiplex PCR method standardization
The standardization of the method was carried out with the
use GBS strains where the presence of at least one out of
seven different DNA factors of GBS was confirmed before
with the application of monoplex PCR (Table 1).
Optimization of the multiplex PCR method was based on the
selection of the appropriate concentration of magnesium ion
(0.625–5.625 mmol/L), primer (0.1–1.0 mmol/L) as well as
determining the appropriate temperature (46–60°C) for all the
seven pairs of primers to anneal to the DNA matrix.
The PCR products were separated after amplification in 2%
agarose gel in 0.5×TBE buffer (Fluka) in the presence of
ethidium bromide (0.25 μg/mL) (Sigma). The final analysis
was conducted with the application of Quantity One software
(BioRad) and gel visualization apparatus GelDoc2000
(BioRad).
After determining the optimal conditions for amplifica-
tion, the method was tested to check its efficacy. For this
purpose, the analysis of selected reference strains possessing
the sought genetic markers was performed. Afterwards, the
examination of 75 GBS isolates which possessed at least
one out of the seven sought DNA sequences and which had
previously been subjected to the genetic analysis with the
use of separate PCR methods described by other authors
(Table 1) was blindly performed. Moreover, six non-GBS
strains belonging to the beta-hemolytic Gram-positive cocci
that can be most frequently confused with GBS were
tested: Streptococcus pyogenes, Enterococcus faecalis,
Streptococcus aureus, and Streptococcus haemolyticus.
Additionally, the multiplex PCR reaction was carried out
using the DNA isolated from the genital tract swabs of
women colonized with GBS in order to check the efficacy
of the designed method in such a case.
Results
The optimal conditions for conducting the amplification of
S. agalactiae DNA were determined for simultaneous de-
tection of seven most frequent genetic factors significant for
diagnostic and epidemiological purposes. The annealing
temperature of the primers was determined as ramp 0.3°C/
s up to 52.0°C. The optimal concentration of specific pairs
of primers was determined in an experimental way and
presented in Table 1. The primer concentration was de-
creased for shorter products, whereas it was increased for
the longer ones.
The total volume of the designed multiplex PCR reaction
was 40 μL and it consisted of: seven pairs of primers
(concentration presented in Table 1); 50 ng of bacterial
DNA; 250 μmol/L of each dNTP (Fermentas); 1.87 mmol/
L MgCl2, 2 U of Taq polymerase (EURx); and KCl buffet
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for polymerase (EURx). The developed program for multi-
plex PCR amplification was devised using the following
thermal profile: 95°C—5 min, 50×(95°C—1 min, ramp
0.3°C to 52°C, 52°C—1 min, 72°C—3 min), 72°C—
10 min (PTC-200, BioRad). The efficacy of the multiplex
PCR method was tested with the application of the group of
reference strains with confirmed presence of the desired
genetic sequences (Fig. 1).
Compatibility with the results obtained from separate
PCR reactions in the monoplex system was 100%.
Furthermore, it was proved that designed multiplex PCR
method applied in DNA samples derived from other Gram-
positive bacteria, such as S. pyogenes, E. faecalis, S. aureus,
and S. haemolyticus, did not provide a positive signal after
gel electrophoresis which meant that it was characteristic
only for S. agalactiae bacteria. Sensitivity of our method
was too low to detect the above-mentioned sequences in
DNA samples isolated directly from the genital tract swabs.
Discussion
Infections triggered off by S. agalactiae are the problems
particularly in newborns which often lead to death due to
occurrence of sepsis or meningitis (Verani et al. 2010). In
recent years, GBS infections among the elderly or the
immunosuppressed patients have been more frequently ob-
served (Thigpen et al. 2011). The classical microbiological
diagnosis of these infections is most frequently reduced to
bacterial culture and assessment of their drug resistance,
which is time-consuming and lowers the chances for effec-
tive treatment. Due to this reason, other diagnostic methods
which will allow simultaneously accurate detection of GBS
presence as well as defining their most important determi-
nants, such as resistance to the most common antibiotics,
serotypes, or affinity to hypervirulent ST17 clone, are essen-
tial. Actually, this can only be achieved by molecular biology
methods which are more specific than methods based on
phenotypic analysis of GBS.
The multiplex PCR method described in this study allows
the simultaneous detection of as many as seven different
DNA targets, which can both confirm the presence of S.
agalactiae bacteria as well as depict the most common
serotypes in Europe and the USA (Ia, III, and V), macrolide
resistance genes (ermB and mefA/E), and affinity to the
hypervirulent ST17 clone (Brimil et al. 2006; Gherardi et
al. 2007; Manning et al. 2009; Poyart et al. 2008). This gives
our method a significant predominance over the commercial
tests since it provides important data as far as clinical and
epidemiological points of view are concerned. In our re-
search in Poland, serotype III was predominant (35%), then
serotype Ia (20%) and serotype V (17%) constituting the
Table 1 Primers, PCR products specific for the studied gene targets, and conditions for the multiplex PCR reaction
Studied targets Primer sequences 5′–3′ Tm [°C]
a Primers PCR products [bp]
Names [μmol/L]b
S. agalactiae TTT CAC CAG CTG TAT TAG AAG TA 55.3 Sag59 0.125 153
GTT CCC TGA ACATTA TCT TTG AT 55.3 Sag190
(Ke et al. 2000)
Ia serotype GG TCA GAC TGG ATT AAT GGT ATG C 64.0 Ia-F 0.25 521
GTA GAA ATA GCC TAT ATA CGT TGA ATG C 64.0 Ia-R 1,826
(Poyart et al. 2007)
III serotype TCC GTA CTA CAA CAG ACT CAT CC 63.0 III-F 0.5 1,826
AGT AAC CGT CCATAC ATT CTA TAA GC 63.0 III-R
(Poyart et al. 2007)
V serotype GAG GCC AAT CAG TTG CAC GTA A 64.0 V-F 0.375 701
AAC CTT CTC CTT CAC ACT AAT CCT 62.0 V-R
(Poyart et al. 2007)
mefA/E gene AGT ATC ATT AAT CAC TAG TGC 46.5 mefA 0.25 348
TTC TTC TGG TAC TAA AAG TGG 48.5 mefE
(Sutcliffe et al. 1996)
erm B gene GGA AAG GTA CTC AAC CAA ATA A 46.5 ermB1 0.375 639
CAT TTG TTA AAT TCA TGG CAA TGA 48.8 ermB2
(Sutcliffe et al. 1996)
ST17 clone ATA CAA ATT CTG CTG ACT ACC G 51.1 ST17S 0.125 210
TTA AAT CCT TCC TGA CCA TTC C 51.1 ST17AS
(Lamy et al. 2006)
a Tm temperature specified by the manufacturer
b Concentration of primers in the multiplex reaction mixture
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total of 72% (Brzychczy-Włoch et al. 2012). The ermB gene
was indicated in 63% of all the isolates with cMLSB phe-
notype and serotype V, whereas the mefA/E genes were
found in 11% of all the isolates (Brzychczy-Włoch et al.
2010; Pinheiro et al. 2009).
The PCR method is very sensitive and theoretically it
allows to detect single copies of DNA sequences in the ana-
lyzed sample. However, the simultaneous amplification of
several different DNA sequences during the single PCR reac-
tion decreases the reaction sensitivity. In the research, this
resulted in the lack of amplification signal while conducting
the PCR in DNA samples isolated directly from the material
from the genital tract. Furthermore, DNA amplification is
sensitive to numerous inhibitors which can be included in
the DNA isolate from the clinical material (Domeika and
Drulyte 2000; Lefevre et al. 2003). In addition, isolation of
nucleic acids from such a material results in the presence of a
significant amount of human DNA sequences which may
interact with bacterial DNA, which evidently lowers PCR
sensitivity (Cogswell et al. 1996).
Designing the multiplex PCR method used to detect the
seven DNA targets in the single reaction of amplification
constitutes a remarkable achievement considering the fact that
it was possible to combine the starters coming from indepen-
dent scientific publications as well as develop one joint am-
plification program in order to obtain considerably different-
sized products of the PCR reaction (153–1,826 bp). What is
more, this method can constitute a perfect tool for diagnostic
and epidemiological screening in hospitals with the access to
diagnostic laboratories equipped with the basic equipment for
Fig. 1 Results of
standardization of the multiplex
PCR for detection of seven
different sequences important
for screening of group B
Streptococcus infection
(1—hypervirulent clone ST17;
2—12403 ATCC, III serotype;
3—BAA611 ATCC, V
serotype; 4—strain with mef A/
E gene; 5—strain with ermB
gene; 6—11360 NCTC; Ia
serotype; 7—the negative
control)
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molecular research. Due to its application, it is possible to
confirm the GBS presence as well as detect the macrolide
resistance genes, the hypervirulent ST17 clones, and the most
common serotypes Ia, III, and V related to high morbidity and
mortality rates in patients.
This multiplex PCR can be used as a screening method to
detect the most frequent determinants of GBS infections. We
also hope that the described method will allow the more
precise testing of cases of suspected GBS infection.
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